A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong ...

Therapy-resistant subclones as drivers of progression in aggressive variant prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not ...

Healthcare providers are increasingly adopting advanced diagnostic and treatment approaches as prostate cancer remains one of ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that ...

A novel theranostic approach that targets RET—a newly identified biomarker for neuroendocrine prostate cancer—enables high-contrast PET imaging and effective, safe treatment for this highly aggressive ...

PSMA PET has become central to prostate cancer imaging as advanced disease incidence rises and prostate-specific membrane ...

Experts are urging officials to rethink their decision on prostate cancer screening, after an MRI approach was shown to slash ...